Body Handbook Catalogue Profile Ranking
Healthcare BODY HANDBOOK
Healthcare ยท ยง651
Preserving Muscle on GLP-1 Therapy
Semaglutide and tirzepatide take off 15 to 20 percent of body weight in a year. What no one mentions with the script: by default about a third of that is lean tissue rather than fat Wilding et al. 2021 โ€” the muscle you climb stairs with and the bone that keeps you off a walker at seventy. Eat enough protein and lift twice a week and the same weight comes off as fat. The catch is the protein, because the drug has killed your appetite.
Do ยท Daily Evidence Emerging Chapter Healthcare

The drug does one thing: it kills hunger. You eat far less, so the weight comes off 1. Eating less also means less protein, and asking nothing heavy of your muscles, so the body sheds them along with the fat. Two levers stop that. Protein at 1.2 to 1.6 grams per kilogram a day, roughly double what most adults eat, gives muscle the material to hold on 2. Lifting gives it a reason to. Together the same kilos come off as fat 3.

The numbers, both ways. On semaglutide the average loss was 14.9 percent of body weight, about 39 percent of it lean mass 1; tirzepatide takes off more, same pattern 4. Flip it with protein and load: in a controlled deficit, one group gained 1.2 kg of muscle while losing 4.8 kg of fat 3. Bolt exercise onto the drug and body composition holds instead of eroding 5.

Both levers from week one, not month six.

How the year splits.

  • Month two: the sessions feel routine, and you're already stronger than you expected; years of carrying weight built real legs underneath.
  • Month six: weight is down, the face rested rather than gaunt, the arms showing. Watching your lifts rise while the scale drops is its own steady mood lift.
  • Year one: same 15 kilos lighter as the drug-only version, but almost all of it fat, muscle near where it started, grip stronger than it's been in a decade 3.
  • Later: taper off and the metabolism you kept makes maintenance normal portions instead of deprivation; the bones held 7.
The fine print โ€” when to skip it, and what people get wrong

Where it goes wrong. Tracking calories down instead of protein up, drifting to soup and toast. Banking all the protein at dinner. Walking instead of lifting. Quitting when the drug stops โ€” post-therapy is where kept muscle pays off 8.

Two things people get wrong. "Lose slowly and muscle takes care of itself": pace barely changes the lean fraction. Protein and load do. "It's mostly water on the scan": the first kilo is water, but after that it's genuine skeletal muscle 1.

Chronic kidney disease: set the protein dose with a renal dietitian rather than the numbers here. History of an eating disorder: an appetite-killing drug plus protein-tracking can mask undereating, so clinician oversight matters more than the protocol.

References
  1. 1Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. link
  2. 2Pasiakos SM, Cao JJ, Margolis LM, et al. (2013). Effects of high-protein diets on fat-free mass and muscle protein synthesis following weight loss: a randomized controlled trial. FASEB Journal. link
  3. 3Longland TM, Oikawa SY, Mitchell CJ, Devries MC, Phillips SM (2016). Higher compared with lower dietary protein during an energy deficit combined with intense exercise promotes greater lean mass gain and fat mass loss: a randomized trial. American Journal of Clinical Nutrition. link
  4. 4Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. link
  5. 5Lundgren JR, Janus C, Jensen SBK, et al. (2021). Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined. New England Journal of Medicine. link
  6. 6Helms ER, Zinn C, Rowlands DS, Brown SR (2014). A systematic review of dietary protein during caloric restriction in resistance trained lean athletes: a case for higher intakes. International Journal of Sport Nutrition and Exercise Metabolism. link
  7. 7Villareal DT, Aguirre L, Gurney AB, et al. (2017). Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults. New England Journal of Medicine. link
  8. 8Rubino D, Abrahamsson N, Davies M, et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. link
ยท
651